TWA
BHVN icon

TCI Wealth Advisors’s Biohaven BHVN Stock Holding History

TCI Wealth Advisors’s Portfolio BHVN Stock Details BHVN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-157
Closed -$2.15K – 447
2023
Q1 		$2.15K Sell
157
-74
-32% -$1.18K ﹤0.01% 1951
2022
Q4 		$3.21K Buy
231
+100
+76% +$1.41K ﹤0.01% 1824
2022
Q3 		$19K Buy
+131
New +$951 ﹤0.01% 668

Other funds holding BHVN

Stifel Financial
Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
RM
RP Management New York $139M AUM 37.98% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Holocene Advisors
Holocene Advisors New York $41.5B AUM 42.97% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

TCI Wealth Advisors's BHVN Position: Q2 2023 in Review

TCI Wealth Advisors sold out of Biohaven (BHVN) in Q2 2023, closing a stake of 157 shares — an estimated $2.15K sold.

TCI Wealth Advisors first reported a position in BHVN in Q3 2022 and held it in 3 quarters. The position peaked at $19K in Q3 2022. 188 funds tracked by Wall St. Rank hold BHVN as of Q2 2023.

  • TCI Wealth Advisors reported no remaining Biohaven position as of Q2 2023 after selling out during the quarter.
  • TCI Wealth Advisors sold 157 Biohaven shares in Q2 2023, an estimated $2.15K.
  • TCI Wealth Advisors first reported a position in Biohaven in Q3 2022 and held it in 3 quarters.
  • TCI Wealth Advisors's Biohaven position peaked at $19K in Q3 2022.
  • 188 funds tracked by Wall St. Rank held Biohaven as of Q2 2023.

Based on TCI Wealth Advisors's 13F filing for Q2 2023, filed 4 Aug 2023.